[ad_1]
Pfizer CEO Albert Burla said Tuesday that he understood concerns about the speed with which drug companies were producing Covid-19 vaccines, but insisted that no cuts had been made.
At the same time, in an event carried out by the International Federation of Associations and Manufacturers of Pharmaceutical Products, talked about a new form of experimental vaccine in which the Pfizer and can be kept in the refrigerator.
It is noted that currently, the vials containing the vaccine must be stored at -70 ° C, so each country has begun to supply special refrigerators for their maintenance.
The Pfizer CEO said the company is trying to find a way to ensure that the vaccine does not need Arctic temperatures for storage. ““We are working on a new form of vaccine that may not require freezing at -70ºC and can be stored in a refrigerator,” he emphasized.
As Britain took the lead among Western countries in vaccinating the coronavirus, raising “hope” around the world, Burla stressed that people must feel confident that it is a safe and effective vaccine. vaccine.
At Tuesday’s event, Pfizer’s chief executive told france24 that the vaccine had been tested “like we test any other vaccine on the market.”
“A big mistake is just one dose of the vaccine”
“Two doses of the vaccine are required to achieve 95% protection levels. “It is a very big mistake for someone to do it with a single dose, when with two the protection almost doubles,” he stressed.
“People with severe allergies should not get the vaccine”
Meanwhile, UK authorities have issued an emergency warning that people with a history of severe allergies should not get the vaccine.
This breaking news comes after allergic reactions from two previously vaccinated NHS staff members. They are both now on the mend.
Read the news from Greece and the world, with the reliability and validity of News247.gr.
[ad_2]
